CN
Drug Modalities
Technical Solutions
ESG
Newsroom
About Us
Contact Us
CN
CN
Home/Newsroom/News

News 2019-10-23

Porton Pharma Solution Ltd (Booth 101A50) will be exhibit in 2019 CPhI Worldwide

Porton Pharma Solution Ltd (Booth 101A50) will be exhibit in 2019 CPhI Worldwide this November in Frankfurt, Germany.

Come and meet our Team!

in 2019 CPhI Worldwide

Others
More

News 2026-09-30

Porton Newsletter - September, 2026 Recap

Porton Recognized by LyncBio Therapeutics for ADC Payload-Linker CMC Capabilities Porton Chongqing Liangjiang Drug Product Manufacturing Site Earns Recertification of ISO 14001 & ISO 45001 PMO Therapeutics: Technical Review and Manufacturing Platform Capabilities

News 2026-09-29

Porton Recognized by LyncBio Therapeutics for ADC Payload-Linker CMC Capabilities

Porton, as the project's CDMO partner, completed process development and manufactured non-GMP toxicology batches and GMP clinical trial materials for LYNC-101's payload-linker.

Become part of Porton's community to access personalized insights and resources.
Subscribe to the Newsletter
By clicking “Subscribe,” you acknowledge that you have read and agree to our Legal Disclaimer, Terms of Use, and Privacy & Cookie Policy. Porton will use the contact information you provide to communicate with you about our products, services, and other relevant updates. You may unsubscribe at any time. For more information about how we protect your privacy and manage your communication preferences, please review our Privacy & Cookie Policy.
US: (609) 860-1300
CN: (86) 23-8608-3200

ⓒ 2026 PORTON Legal Disclaimer| Privacy & Cookie Policy


This website provides information on products tailored for a diverse audience and may include product details or information that are not readily accessible or valid in your country. Please note that we do not accept any responsibility for accessing such information in a manner that may violate any legal processes, regulations, registrations, or usage guidelines in your country of origin.

Become part of Porton's community to access personalized insights and resources.
Submit
By clicking “Subscribe,” you acknowledge that you have read and agree to our Legal Disclaimer, Terms of Use, and Privacy & Cookie Policy. Porton will use the contact information you provide to communicate with you about our products, services, and other relevant updates. You may unsubscribe at any time. For more information about how we protect your privacy and manage your communication preferences, please review our Privacy & Cookie Policy.

ⓒ 2026 PORTON Legal Disclaimer| Privacy & Cookie Policy


US: (609) 860-1300
CN: (86) 23-8608-3200